Application value of CT radiomic nomogram in predicting T790M mutation of lung adenocarcinoma

被引:3
|
作者
Li, Xiumei [1 ]
Chen, Jianwei [2 ]
Zhang, Chengxiu [3 ]
Han, Zewen [1 ]
Zheng, Xiuying [1 ]
Cao, Dairong [1 ,4 ,5 ,6 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Fuzhou 350005, Fujian, Peoples R China
[2] Fujian Prov Canc Hosp, Dept Pathol, Fuzhou 350014, Fujian, Peoples R China
[3] East China Normal Univ, Sch Phys & Elect Sci, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China
[4] Fujian Med Univ, Affiliated Hosp 1, Natl Reg Med Ctr, Dept Radiol, Binhai Campus, Fuzhou 350212, Fujian, Peoples R China
[5] Fujian Med Univ, Affiliated Hosp 1, Fujian Key Lab Precis Med Canc, Fuzhou 350005, Fujian, Peoples R China
[6] Fujian Med Univ, Affiliated Hosp 1, Key Lab Radiat Biol, Fujian Higher Educ Inst, Fuzhou 200062, Peoples R China
关键词
Lung adenocarcinoma; Radiomics; Computed tomography; T790M; CANCER;
D O I
10.1186/s12890-023-02609-y
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundThe purpose of this study was to develop a radiomic nomogram to predict T790M mutation of lung adenocarcinoma base on non-enhanced CT lung images.MethodsThis retrospective study reviewed demographic data and lung CT images of 215 lung adenocarcinoma patients with T790M gene test results. 215 patients (including 52 positive) were divided into a training set (n = 150, 36 positive) and an independent test set (n = 65, 16 positive). Multivariate logistic regression was used to select demographic data and CT semantic features to build clinical model. We extracted quantitative features from the volume of interest (VOI) of the lesion, and developed the radiomic model with different feature selection algorithms and classifiers. The models were trained by a 5-fold cross validation strategy on the training set and assessed on the test set. ROC was used to estimate the performance of the clinical model, radiomic model, and merged nomogram.ResultsThree demographic features (gender, smoking, emphysema) and ten radiomic features (Kruskal-Wallis as selection algorithm, LASSO Logistic Regression as classifier) were determined to build the models. The AUC of the clinical model, radiomic model, and nomogram in the test set were 0.742(95%CI, 0.619-0.843), 0.810(95%CI, 0.696-0.907), 0.841(95%CI, 0.743-0.938), respectively. The predictive efficacy of the nomogram was better than the clinical model (p = 0.042). The nomogram predicted T790M mutation with cutoff value was 0.69 and the score was above 130.ConclusionThe nomogram developed in this study is a non-invasive, convenient, and economical method for predicting T790M mutation of lung adenocarcinoma, which has a good prospect for clinical application.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Acquired T790M resistance do afatinib in EGFR mutated lung adenocarcinoma
    Miyazaki, Kunihiko
    Sato, Shinya
    Kodama, Takahide
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2016, 64 (04): : 317 - 318
  • [22] Exploring the impact of EGFR T790M neighboring SNPs on ARMS-based T790M mutation assay
    Xu, Sanpeng
    Duan, Yaqi
    Lou, Liping
    Tang, Fengjuan
    Shou, Juan
    Wang, Guoping
    ONCOLOGY LETTERS, 2016, 12 (05) : 4238 - 4244
  • [23] EGFR T790M Mutation A Double Role in Lung Cancer Cell Survival?
    Suda, Kenichi
    Onozato, Ryoichi
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (01) : 1 - 4
  • [24] Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma
    Ying Fan
    Yue Dong
    Huan Wang
    Hongbo Wang
    Xinyan Sun
    Xiaoyu Wang
    Peng Zhao
    Yahong Luo
    Xiran Jiang
    European Radiology, 2022, 32 : 6739 - 6751
  • [25] Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma
    Fan, Ying
    Dong, Yue
    Wang, Huan
    Wang, Hongbo
    Sun, Xinyan
    Wang, Xiaoyu
    Zhao, Peng
    Luo, Yahong
    Jiang, Xiran
    EUROPEAN RADIOLOGY, 2022, 32 (10) : 6739 - 6751
  • [26] Monitoring the EGFR T790M mutation in liquid biopsy in patients with lung cancer
    Cardos, G.
    Motoc, R.
    Leonte, D. G. N.
    Simion, G.
    Gurban, P.
    Iordache, F.
    Iorga, P.
    Apostol, P. P.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 436 - 437
  • [27] Presence of the minor EGFR T790M mutation is associated with drug-sensitive EGFR mutations in lung adenocarcinoma patients
    Hashida, Shinsuke
    Soh, Junichi
    Toyooka, Shinichi
    Tanaka, Tomoaki
    Furukawa, Masashi
    Shien, Kazuhiko
    Yamamoto, Hiromasa
    Asano, Hiroaki
    Tsukuda, Kazunori
    Hagiwara, Koichi
    Miyoshi, Shinichiro
    ONCOLOGY REPORTS, 2014, 32 (01) : 145 - 152
  • [28] EGFR L718Q mutation occurs without T790M mutation in a lung adenocarcinoma patient with acquired resistance to osimertinib
    Ma, Lei
    Chen, Rui
    Wang, Fang
    Ma, Li-Li
    Yuan, Ming-Ming
    Chen, Rong-Rong
    Liu, Jiang
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (09)
  • [29] A Radiomics-clinical Nomogram based on CT Radiomics to Predict Acquired T790M Mutation Status in Non-small Cell Lung Cancer Patients
    Xiong, Wanrong
    Yu, Xiufang
    Zhou, Tong
    Huang, Huizhen
    Zhao, Zhenhua
    Wang, Ting
    CURRENT MEDICAL IMAGING, 2024, 20
  • [30] Tissue Is the Issue for Diagnosis of EGFR T790M Mutation
    Khan, Jenna
    Pritchard, Colin C.
    Martins, Renato G.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) : E91 - E92